Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Germany
Clinical trial register · Germany

Clinical Trials in Germany

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5081 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:18 UTC
5081
Studies in scope
all four open statuses
2880
Recruiting now
open to new participants
985
Lead sponsors
across recruiting studies
Top sites
Berlin 18 Hamburg 13 Essen 12 Frankfurt 11 München 10
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca188 Novartis Pharmaceuticals142 Hoffmann-La Roche99 Merck Sharp & Dohme LLC98 Eli Lilly and Company98 Charite University, Berlin, Germany95 Janssen Research & Development, LLC90 University Hospital Tuebingen87 AbbVie79 Universitätsklinikum Hamburg-Eppendorf78 Bristol-Myers Squibb67 Sanofi65 Boehringer Ingelheim61 Pfizer56 University Hospital Heidelberg52 Novo Nordisk A/S51 Amgen49 GlaxoSmithKline49 University of Erlangen-Nürnberg Medical School47 Technical University of Munich47 Heinrich-Heine University, Duesseldorf45 Technische Universität Dresden44 Bayer32 Takeda31 University of Ulm29 Show all 1399 Clear sponsor filter
Site location
Berlin18 Hamburg13 Essen12 Frankfurt11 München10 Mainz10 Cologne10 Leipzig10 Dresden8 Lübeck7 Mannheim6 Frankfurt am Main5 Düsseldorf5 Tübingen5 Giessen4 Hanover4 Bonn4 Minden3 Münster3 Kiel3 Würzburg3 Augsburg3 Erlangen3 Darmstadt3 Aachen3 Show all 71
All 71 locations
Target enrolment
to

Trials in this register

49 of 5081 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Recruiting
GlaxoSmithKline
Phase 2
200
Frankfurt, Hamburg, Karlsruhe, Koblenz, München
2026-04-15
Recruiting
GlaxoSmithKline
Phase 3
1,250
Leipzig
2025-12-12
Recruiting
GlaxoSmithKline
Phase 3
450
München, Cologne, Essen, Dresden, Berlin, Mannheim, Tübingen
2025-12-03
Recruiting
GlaxoSmithKline
Phase 2
363
Bendorf, Berlin, Frankfurt, Geesthacht, Hamburg, München
2025-10-30
Recruiting
GlaxoSmithKline
Phase 3
1,196
Berlin, Frankfurt, Mainz, München
2025-10-20
Recruiting
GlaxoSmithKline
Phase 3
420
Karlsruhe, Löwenstein, Stuttgart, Augsburg, Chemnitz, Esslingen am Neckar, Heidelberg, Immenhausen
2025-08-11
Active, closed
GlaxoSmithKline
Phase 2
168
Giessen
2025-08-06
Recruiting
GlaxoSmithKline
Phase 3
961
Munich, Fürstenwalde, Darmstadt, Giessen, Offenbach, Rheine, Bendorf, Halle
2025-06-23
Recruiting
GlaxoSmithKline
Phase 3
981
Löwenstein, Donaustauf, Peine, Essen, Ahrensburg, Berlin, Bonn, Frankfurt am Main
2025-06-20
Recruiting
GlaxoSmithKline
Phase 1/2
346
Frankfurt am Main, Bochum, Düsseldorf, Lübeck, München
2025-06-11
Recruiting
GlaxoSmithKline
Phase 2
80
Münster, Dresden, Leipzig
2025-06-05
Recruiting
GlaxoSmithKline
Phase 1/2
305
München, Mainz, Cologne, Leipzig
2025-03-04
Recruiting
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
NCT06517875Primary Myelofibrosis, Myelofibrosis; Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis
DrugsMomelotinib·Reblozyl·Luspatercept
GlaxoSmithKline
Phase 2
68
Essen, Jena, Lübeck, Mannheim
2025-02-28
Active, closed
GlaxoSmithKline
Phase 2
307
Fürstenwalde, Darmstadt, Neu-Isenburg, Schleswig, Bendorf, Berlin, Frankfurt, Leipzig
2025-02-10
Recruiting
GlaxoSmithKline
Phase 3
520
Jena, Lübeck, Chemnitz, Cologne, Dresden, Hamburg, Hanover, Mainz
2024-12-16
Active, closed
GlaxoSmithKline
Phase 1
86
Cologne, Lübeck
2024-12-11
Active, closed
GlaxoSmithKline
Phase 2
283
Hanover, Berlin, Münster
2024-11-11
Recruiting
GlaxoSmithKline
Phase 2
393
Bochum, Berlin, Kiel, Leipzig, Mainz
2024-09-27
Recruiting
GlaxoSmithKline
Phase 3
440
Essen, Minden, Mainz, Würzburg
2024-09-11
Active, closed
GlaxoSmithKline
Phase 3
10,212
Weinheim, Dachau, Munich, Hanover, Cologne, Essen, Goch, Freiberg
2024-08-01
Recruiting
GlaxoSmithKline
Phase 3
150
Bonn, Frankfurt
2024-07-19
Active, closed
GlaxoSmithKline
Phase 3
88
Hamburg
2024-06-10
Active, closed
GlaxoSmithKline
Phase 4
302
Mainz, Herne, Lübeck, Meerbusch
2024-06-06
Recruiting
GlaxoSmithKline
Phase 3
864
Augsburg, Berlin, Erlangen, Essen, Giessen, Hamburg, Neuruppin, Straubing
2024-03-21
Active, closed
GlaxoSmithKline
Phase 4
177
Darmstadt, Frankfurt am Main, Aachen, Bonn, Hohenstein-Ernsttal, Schleswig
2024-03-20
Active, closed
GlaxoSmithKline
Phase 1
127
Hanover, Schwerin, Ahrensburg, Berlin, Dresden, Frankfurt, Hamburg, Leipzig
2023-11-27
Active, closed
GlaxoSmithKline
Phase 2
316
Frankfurt am Main, Essen, Aachen, Berlin, Giessen, Hamburg, Regensburg, Ulm
2023-11-14
Recruiting
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
NCT05878717Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic
DrugBelimumab
GlaxoSmithKline
Phase 2/3
300
Minden, Mainz, Cologne, Düsseldorf, Tübingen
2023-09-13
Recruiting
GlaxoSmithKline
Phase 3
892
Berlin, Düsseldorf, Frankfurt, Halle, Lübeck, Mannheim, München
2023-08-01
Active, closed
GlaxoSmithKline
Phase 2
154
Berlin, Dresden, Düsseldorf, Frankfurt, München
2023-04-03
Active, closed
GlaxoSmithKline
Phase 2
351
Essen, Großhansdorf, Jena, Berlin, Heidelberg
2022-10-14
Active, closed
GlaxoSmithKline
Phase 3
110
Mannheim
2022-09-06
Active, closed
GlaxoSmithKline
Phase 3
3,038
Wangen, Weinheim, Rednitzhembach, Wallerfing, Flörsheim, Cologne, Essen, Goch
2022-08-10
Active, closed
GlaxoSmithKline
Phase 1/2
20
Hamburg
2022-07-19
Active, closed
GlaxoSmithKline
Phase 3
163
Freiburg im Breisgau, Minden
2022-07-14
Active, closed
GlaxoSmithKline
Phase 2
366
Frankfurt am Main, Düsseldorf, Berlin, Hamburg
2021-12-14
Active, closed
GlaxoSmithKline
Phase 2
305
Schönau, Bramsche, Herxheim, Leipzig, Mannheim, Schweigen-Rechtenbach
2021-11-18
Active, closed
GlaxoSmithKline
Phase 3
40
Berlin, Cologne, Erlangen, Essen, Mannheim, München, Ulm
2021-06-28
Active, closed
GlaxoSmithKline
Phase 3
1,720
Essen, Goch, Hamburg, Mainz, München, Wallerfing, Würzburg
2021-02-15
Active, closed
GlaxoSmithKline
Phase 2/3
758
Augsburg, Bad Berka, Berlin, Bonn, Cologne, Dresden, Essen, Frankfurt
2020-12-08
Active, closed
GlaxoSmithKline
Phase 3
302
Mainz, Tübingen, Würzburg
2020-10-01
Active, closed
GlaxoSmithKline
Phase 3
242
Erlangen, Münster
2020-07-14
Active, closed
GlaxoSmithKline
Phase 1/2
106
Frankfurt, Kiel, Leipzig
2020-06-08
Active, closed
GlaxoSmithKline
Phase 3
325
Berlin, Tübingen
2020-04-02
Active, closed
GlaxoSmithKline
Phase 1
118
Dresden, Hamburg, Schwerin, Tübingen
2019-12-18
Active, closed
GlaxoSmithKline
Phase 2
25
Berlin, Saint Augustin
2019-11-28
Active, closed
GlaxoSmithKline
Phase 1/2
25
Hamburg
2019-11-26
Active, closed
GlaxoSmithKline
Phase 1/2
208
Frankfurt, Hamburg, Kiel, Leipzig
2019-10-07
Active, closed
GlaxoSmithKline
Phase 2
237
Aachen, Cologne, Dresden, Halle, Leipzig, Lübeck, Mainz
2018-05-03
Rows per page Showing 1–49 of 49
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 November 2026. https://priyalifescience.com/clinical-trials-germany

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,081 studies in total at the last sync on 13 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 49 of those studies that match the filters currently applied.

How many clinical trials are recruiting in Germany?

19 of the 49 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 30 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase, 49 studies
PhaseStudiesRecruitingShare
Phase 3211142.9%
Phase 215530.6%
Phase 1/26212.2%
Phase 1306.1%
Phase 2/3214.1%
Phase 4204.1%

Most active sponsors

Lead sponsors with the most studies
Lead sponsorStudiesRecruiting
GlaxoSmithKline4919

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Multiple Myeloma (9) Pulmonary Disease, Chronic Obstructive (4) Respiratory Syncytial Virus Infections (3) Lung Cancer, Non-Small Cell (3) Asthma (3) Hepatitis B (2) Systemic Lupus Erythematosus (2) Neoplasms, Head and Neck (2) Gastrointestinal Neoplasms (2) Primary Myelofibrosis (2) Systemic Sclerosis Associated Interstitial Lung Disease (1) Scleroderma, Systemic (1) Chronic Hepatitis B Virus Infection (1) Eosinophilic Granulomatosis With Polyangiitis (1) Neoplasms, Lung (1)
→

Browse trials by site location

Berlin (18) Hamburg (13) Essen (12) Frankfurt (11) München (10) Mainz (10) Cologne (10) Leipzig (10) Dresden (8) Lübeck (7) Mannheim (6) Frankfurt am Main (5) Düsseldorf (5) Tübingen (5) Giessen (4)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.